Towards a definition of sarcopenia--results from epidemiologic studies.
The age-related loss of muscle mass, also called sarcopenia, is receiving increasing attention in aging research. While the concept is frequently being used in research settings and introduced to clinical settings, thus far no consensus on its definition has been established. This article provides an overview of the history of sarcopenia definitions proposed in the literature thus far. It will describe the methodology used to develop the cutpoints for low muscle mass (or strength) in large epidemiological studies, how sarcopenia based on these cutpoints relates to functional outcomes, and the advantages and disadvantages of the different definitions. This overview will contribute to the current need to develop a consensus definition of sarcopenia which can be used in all relevant settings.
Visser
M
M
Department of Health Sciences, Faculty of Earth and Life Sciences, VU University Amsterdam, De Boelelaan 1085, Amsterdam, the Netherlands. marjolein.visser@falw.vu.nl
D000368:Aged; D000375:Aging / Q000502:physiology; D032921:Consensus; D006801:Humans; D053580:Muscle Strength / Q000502:physiology; D018482:Muscle, Skeletal / Q000473:pathology / Q000503:physiopathology*; D012016:Reference Values; D055948:Sarcopenia / Q000503:physiopathology*; D009626:Terminology as Topic